BL 3730

Drug Profile

BL 3730

Alternative Names: BL-3730

Latest Information Update: 01 May 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Pharmaceutical
  • Class
  • Mechanism of Action Leucocyte elastase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Multiple organ failure; Reperfusion injury; Respiratory distress syndrome

Most Recent Events

  • 30 Apr 2001 Preclinical development for Multiple organ failure in Japan (Unknown route)
  • 30 Apr 2001 Preclinical development for Reperfusion injury in Japan (Unknown route)
  • 30 Apr 2001 Preclinical development for Respiratory distress syndrome in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top